Aurora Spine マネジメント

マネジメント基準チェック /34

Aurora Spineの CEO はTrent Northcuttで、 Feb2012年に任命され、の在任期間は 12.75年です。の年間総報酬は$ 175.23Kで、 77.8%給与と22.2%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の6.8%を直接所有しており、その価値は$ 1.61M 。経営陣と取締役会の平均在任期間はそれぞれ11.8年と11.3年です。

主要情報

Trent Northcutt

最高経営責任者

US$175.2k

報酬総額

CEO給与比率	77.8%
CEO在任期間	12.8yrs
CEOの所有権	6.8%
経営陣の平均在職期間	11.8yrs
取締役会の平均在任期間	11.3yrs

経営陣の近況

Recent updates

CEO報酬分析

Aurora Spine の収益と比較して、Trent Northcutt の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	-US$636k
Jun 30 2024	n/a	n/a	-US$956k
Mar 31 2024	n/a	n/a	-US$1m
Dec 31 2023	US$175k	US$136k	-US$2m
Sep 30 2023	n/a	n/a	-US$2m
Jun 30 2023	n/a	n/a	-US$2m
Mar 31 2023	n/a	n/a	-US$2m
Dec 31 2022	US$123k	US$106k	-US$2m
Sep 30 2022	n/a	n/a	-US$2m
Jun 30 2022	n/a	n/a	-US$2m
Mar 31 2022	n/a	n/a	-US$2m
Dec 31 2021	US$127k	US$111k	-US$2m
Sep 30 2021	n/a	n/a	-US$1m
Jun 30 2021	n/a	n/a	-US$793k
Mar 31 2021	n/a	n/a	-US$58k
Dec 31 2020	US$143k	US$131k	-US$232k
Sep 30 2020	n/a	n/a	-US$777k
Jun 30 2020	n/a	n/a	-US$2m
Mar 31 2020	n/a	n/a	-US$2m
Dec 31 2019	US$143k	US$131k	-US$1m
Sep 30 2019	n/a	n/a	-US$756k
Jun 30 2019	n/a	n/a	-US$199k
Mar 31 2019	n/a	n/a	-US$114k
Dec 31 2018	US$157k	US$125k	-US$68k
Sep 30 2018	n/a	n/a	-US$877k
Jun 30 2018	n/a	n/a	-US$1m
Mar 31 2018	n/a	n/a	-US$2m
Dec 31 2017	US$137k	US$125k	-US$2m

報酬と市場: Trentの総報酬 ($USD 175.23K ) は、 US市場 ($USD 647.72K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Trentの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Trent Northcutt (57 yo)

12.8yrs

在職期間

US$175,227

報酬

Mr. Trent J. Northcutt is the Chief Executive Officer and President at Aurora Spine Corporation since February 2012. He is a Founder of Aurora Spine Corporation. Mr. Northcutt served as Vice President at S...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Trent Northcutt	Founder	12.8yrs	US$175.23k	6.8% $ 1.4m
Chad Clouse	Chief Financial Officer	4.3yrs	US$168.37k	0.0077% $ 1.6k
Laszlo Garamszegi	CTO & Founder	11.8yrs	US$151.07k	データなし
David Meyer	VP, Chief Legal Officer & Secretary	no data	US$143.07k	データなし
Matthew Goldstone	Chief Commercial Officer	no data	データなし	データなし

11.8yrs

平均在職期間

経験豊富な経営陣: ASAP.Fの経営陣は経験豊富で経験豊富です（平均在職期間は11.8年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Trent Northcutt	Founder	11.3yrs	US$175.23k	6.8% $ 1.4m
David Rosenkrantz	Independent Chairman	11.3yrs	データなし	15.87% $ 3.2m
Tracy Graf	Independent Director	11.3yrs	データなし	0.54% $ 110.9k
Joseph MacLellan	Independent Director	11.3yrs	データなし	0.18% $ 37.8k
James Snow	Independent Director	11.3yrs	データなし	0.77% $ 158.2k
Michael Seid	Independent Director	11.3yrs	データなし	0.13% $ 25.6k

11.3yrs

平均在職期間

59.5yo

平均年齢

経験豊富なボード: ASAP.Fの取締役会は経験豊富で経験豊富です ( 11.3年の平均在任期間)。

Aurora Spine マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Aurora Spine Corporation, Annual General Meeting, Jun 26, 2024

Aurora Spine Corporation, Annual General Meeting, Jun 28, 2023

Recent updates

Aurora Spine Corporation Announces Release of Its Hydra Osteo Onyx Lumbar System

Aurora Spine Corporation to Report Q1, 2024 Results on May 13, 2024

Aurora Spine Corporation, Annual General Meeting, Jun 26, 2024

Aurora Spine Corporation to Showcase Sacroiliac Joint (Si Joint) Fusion Products At North American Neuromodulation Society Annual Meeting

Aurora Spine Corporation Announces Newly Published Paper on First 6-Month Clinical Evaluation of its ZIP™? Fusion Implant

Aurora Spine Corporation announced that it has received CAD 1.933782 million in funding

Aurora Spine Corporation Announces Full Release of its SiLO TFX™? MIS Sacroiliac Joint Fixation System

Aurora Spine Corporation Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study

Aurora Spine Corporation to Report Q1, 2023 Results on May 24, 2023

Aurora Spine Corporation, Annual General Meeting, Jun 28, 2023

Aurora Spine Corporation to Report Q3, 2022 Results on Nov 21, 2022

Aurora Spine Corporation Announces Positive Interim Results from Clinical Study Using Zip(TM) MIS Interspinous Fusion System

Aurora Spine Corporation Announces FDA 510(K) Clearance for Its Silo TFX MIS Sacroiliac Joint Fixation System

Aurora Spine Corporation to Report Q2, 2022 Results on Aug 29, 2022

Aurora Spine Announces New FDA Indication Clearance of Lumbar Spinal Stenosis for Its ZIP™ Series of MIS Implants

Aurora Spine Corporation Receives FDA 510(K) Clearance for Its Dexa Solo-LTM Spinal Fusion System

Aurora Spine Corporation to Report Q1, 2022 Results on May 23, 2022

Aurora Spine Corporation Announces Initial Implantation of the First Bone Density Matched DEXA-C Cervical Interbody Fusion Device

Aurora Spine Corporation Provides Revenue Guidance for Fourth Quarter and Full Year 2021

Aurora Spine Corporation Receives Notice of Allowance for Patent for Spinal Implant for Motion Preservation or Fusion

Aurora Spine Corporation Completes First Anterior Cervical Discectomy and Fusion Procedures with its Proprietary APOLLOTM Anterior Cervical Plate

Aurora Spine Corporation Announces Newly Published Paper on Need for A Bone Mineral Density-Matched Interbody Cage

Aurora Spine Corporation Will Showcase Its New FDA-Cleared DEXA-C Anterior Fusion Cages At the North American Spine Society Annual Meeting

Aurora Spine Corporation announced that it has received CAD 6.508139 million in funding

Aurora Spine Corporation Provides Revenue Guidance for the Year 2021

Aurora Spine Corporation Announces First Patients in Multicenter Study of ZIP® Interspinous Fixation Device

Aurora Spine Corporation Announces FDA 510(K) Clearance for DEXA-C Cervical Interbody System

Aurora Spine Corporation Provides Revenue Guidance for the Year 2021

Aurora Spine Corporation Receives Irb Approval to Commence Registration for Multicenter Study of Its Silo™ Device for Si Joint Pain

Aurora Spine Corporation Announces Launch of its SiLOTM Posterior SI Joint Fusion System

Aurora Spine Corporation(TSXV:ASG) dropped from S&P/TSX Venture Composite Index

Aurora Spine Plans A Major Multicenter Study of Its ZIPTM Interspinous Fixation Device for Relief of Back Pain

Aurora Spine Corporation Announces Commercial Launch of The SOLO™ System

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34